LadRx Corporation (CYTR)

1 member of Congress has disclosed 3 trades in LadRx Corporation (CYTR) via STOCK Act filings. The most recent disclosure was a purchase by Roger Marshall on 31 July 2017. Aggregate disclosed activity totals roughly $24K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for CYTR
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for CYTR

3 transactions
Compliance: 0%
Roger Marshall31 Jul 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall31 Jul 201713 Aug 2020PurchaseStock$1,001 - $15,000N/A
Roger Marshall31 Jul 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$0

Volume

942

Beta

2.10

P/E Ratio

-0.25

Fundamentals

EPS

$-0.35

Div. Yield

11620.00%

Open

$0.09

Day Range

$0.09 – $0.09

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
OTC · USD
Country
US
CEO
Steven Kriegsman
IPO Date
1986-11-10
Website
www.cytrx.com

LadRx Corporation is a biopharmaceutical firm focused on identifying and advancing treatments for cancer patients. Its primary drug candidate, aldoxorubicin, which is a modified variant of the anti-cancer medication doxorubicin, is currently in late-...

Earnings

Recent Quarters

Q2 202330 Sept
EPS$-1.65
Q1 202330 Jun
EPS$6.45
Q4 202231 Mar
EPS$-26.18
Q3 202231 Dec
EPS$-109.57
Q3 202210 Nov
EPS$-29.62
Q2 202211 Aug
EPS$-0.02
Q1 202212 May
EPS$-0.03
Q4 202123 Mar
EPS$-0.23
Q3 202112 Nov
EPS$-0.04
Q1 202130 Jun
EPS$-0.03
Q1 202113 May
EPS$-0.04
Q4 202025 Mar
EPS$-0.04
Q3 202016 Nov
EPS$-0.08
Q1 202030 Jun
EPS$-0.04
Q4 201931 Mar
EPS$-0.04
Q4 201927 Mar
EPS$-0.09
Q3 201914 Nov
EPS$-0.04
Q2 20199 Aug
EPS$-0.04
Q1 201915 May
EPS$-0.05
Beat 16.7%
Q4 201829 Mar
EPS$-0.07
Beat 0.0%
Q3 20182 Nov
EPS$-0.10
Miss 11.1%
Q2 20186 Aug
EPS$-0.10
Beat 44.4%
Q1 20188 May
EPS$-0.15
Beat 37.5%
Q4 201716 Mar
EPS$-0.16
Q3 20178 Nov
EPS$-0.19
Q2 20173 Aug
EPS$-0.62
Q1 201710 May
EPS$-0.58
Q4 201615 Mar
EPS$-0.36
Beat 45.5%
Q3 20169 Nov
EPS$-0.78
Beat 0.0%
Q2 201629 Jul
EPS$-1.62
Miss 42.1%
Q1 201610 May
EPS$-1.14
Beat 26.9%
Q4 201511 Mar
EPS$-0.35
Miss 75.0%
Q3 20153 Nov
EPS$-0.11
Beat 54.2%
Q2 20153 Aug
EPS$-0.21
Beat 22.2%
Q1 20151 May
EPS$-0.31
Miss 47.6%
Q4 201410 Mar
EPS$-0.24
Beat 11.1%
Q3 20144 Nov
EPS$-0.10
Beat 58.3%
Q2 20146 Aug
EPS$-1.68
Miss 40.0%
Q1 20141 May
EPS$0.48
Beat 145.7%
Q4 20135 Mar
EPS$-4.62
Miss 366.7%
Q3 201329 Oct
EPS$-1.98
Miss 50.0%
Q2 20136 Aug
EPS$-0.66
Beat 42.1%
Q1 20139 May
EPS$-1.38
Miss 50.0%
Q4 201211 Mar
EPS$1.50
Beat 222.9%
Q3 20129 Nov
EPS$0.42
Beat 123.0%
Q2 20129 Aug
EPS$-3.78
Miss 110.0%
Q1 201210 May
EPS$-2.94
Miss 55.6%
Q4 201113 Mar
EPS$-1.26
Beat 14.3%
Q3 20118 Nov
EPS$-0.17
Beat 88.2%
Q2 20119 Aug
EPS$-1.26
Beat 50.0%
Q1 20115 May
EPS$-2.52
Miss 100.0%
Q3 201031 Dec
EPS$1.59
Q3 20108 Nov
EPS$-1.68
Beat 16.8%
Q2 20109 Aug
EPS$0.42
Beat 121.1%
Q1 20106 May
EPS$-0.42
Beat 72.2%
Q4 200915 Mar
EPS$-1.26
Beat 14.9%
Q3 20099 Nov
EPS$1.68
Beat 300.0%
Q2 200910 Aug
EPS$-0.84
Beat 47.8%
Q1 200911 May
EPS$-1.68
Miss 15.1%
Q4 200813 Mar
EPS$-1.68
Beat 0.0%
Q3 20087 Nov
EPS$-5.88
Miss 180.0%
Q2 200811 Aug
EPS$-2.52
Miss 20.0%
Q1 200819 May
EPS$-2.94
Beat 0.0%
Q1 20082 Apr
EPS$-2.94
Beat 4.5%
Q3 200714 Nov
EPS$-2.10
Beat 45.9%
Q2 200710 Aug
EPS$-2.94
Beat 0.0%
Q1 200710 May
EPS$-2.52
Beat 0.0%
Q1 20073 Apr
EPS$-2.52
Miss 20.0%
Q2 200630 Sept
EPS$-1.85
Q1 200630 Jun
EPS$-3.28
Q1 200622 May
EPS$-2.94
Miss 16.7%
Q4 200531 Mar
EPS$-2.52
Beat 14.3%
Q3 200515 Nov
EPS$-2.52
Beat 20.0%
Q2 200515 Aug
EPS$-3.36
Miss 14.3%
Q1 200516 May
EPS$-2.94
Beat 12.5%
Q4 200431 Mar
EPS$-6.30
Miss 130.8%
Q3 20043 Nov
EPS$-3.36
Beat 15.8%
Q2 200418 Aug
EPS$-5.04
Beat 0.0%
Q1 200417 May
EPS$-3.78
Miss 80.0%
Q3 200331 Dec
EPS$-11.02
Q2 200330 Sept
EPS$-4.16
Q1 200330 Jun
EPS$-8.61
Q4 200231 Mar
EPS$-1.78
Q3 200231 Dec
EPS$-5.05
Q2 200230 Sept
EPS$-5.31
Q1 200230 Jun
EPS$-3.36
Q4 200131 Mar
EPS$-0.68
Q3 200131 Dec
EPS$9.27
Q2 200130 Sept
EPS$-4.10
Q1 200130 Jun
EPS$-5.02
Q4 200031 Mar
EPS$-4.79
Q3 200031 Dec
EPS$4.81
Q2 200030 Sept
EPS$-2.56
Q1 200030 Jun
EPS$-0.01
Q4 199931 Mar
EPS$-4.68
Q3 199931 Dec
EPS$-22.07
Q2 199930 Sept
EPS$-26.46
Q1 199930 Jun
EPS$-14.70
Q4 199831 Mar
EPS$-18.06
Q3 199831 Dec
EPS$-38.86
Q2 199830 Sept
EPS$-10.92
Q1 199830 Jun
EPS$19.32
Q4 199731 Mar
EPS$-5.04
Q3 199731 Dec
EPS$-11.34
Q3 199723 Oct
EPS$-7.56
Miss 28.6%
Q2 199722 Jul
EPS$-13.02
Miss 158.3%
Q4 199631 Mar
EPS$-3.78
Q3 199631 Dec
EPS$-11.88
Q2 199630 Sept
EPS$-6.30
Q1 199630 Jun
EPS$-6.30
Q4 199531 Mar
EPS$-7.14
Q3 199531 Dec
EPS$-10.98
Q2 199530 Sept
EPS$-10.08
Q1 199530 Jun
EPS$-18.48
Q4 199431 Mar
EPS$-18.48
Q4 199421 Feb
EPS$-11.76
Miss 16.7%
Q3 199421 Oct
EPS$-10.08
Beat 33.3%
Q2 199422 Jul
EPS$-10.08
Beat 20.0%
Q4 199331 Mar
EPS$-8.40
Q4 199318 Feb
EPS$-10.08
Beat 14.3%
Q3 199319 Oct
EPS$-5.04
Beat 40.0%
Q2 199320 Jul
EPS$-1.68
Beat 66.7%
Q1 199327 Apr
EPS$1.07
Beat 112.7%
Q4 199218 Feb
EPS$-1.68
Beat 50.0%
Q2 199230 Sept
EPS$0.54
Q1 199230 Jun
EPS$1.09
Q3 199131 Dec
EPS$-1.68
Q2 199130 Sept
EPS$8.40
Q1 199130 Jun
EPS$10.08
Q4 199031 Mar
EPS$5.04
Q3 199031 Dec
EPS$-0.84
Q2 199030 Sept
EPS$-1.68
Q4 198931 Mar
EPS$-5.04
Q3 198931 Dec
EPS$-17.92
Q2 198930 Sept
EPS$-6.72

3 politicians traded within 30 days

Dividends

Dividend History

7 Mar 2008
Amount $10.4580

Stock Splits

Split History

1 Nov 2017Reverse Split
Ratio1:6
16 May 2012Reverse Split
Ratio1:7
7 Mar 2008Stock Split
Ratio1250:1077
6 Feb 1996Reverse Split
Ratio1:4

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CYTR

Which members of Congress have traded CYTR?
1 member of Congress has disclosed 3 trade in LadRx Corporation (CYTR) under the STOCK Act: Roger Marshall.
When was CYTR most recently disclosed by Congress?
The most recent CYTR disclosure was a purchase by Roger Marshall on 31 July 2017.
What is the total disclosed congressional trading volume for CYTR?
Members of Congress have disclosed approximately $24K in CYTR purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CYTR?
This CYTR page updates as soon as new STOCK Act disclosures are filed for LadRx Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.